In 2011, Bretones and colleagues observed that in human chronic myeloid leukemia (CML), K562 cells the conditional expression of MYC induced overexpression of SKP2 [37]. Here, SKP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.